Protalix Biotherapeutics, Inc. (PLX)
2.64
-0.02
(-0.75%)
USD |
NYAM |
Sep 16, 15:34
Protalix Biotherapeutics Price : 2.64 for Sept. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 2.75 | 2.75 | 2.64 | 2.66 | 812742.0 |
| Sep 14, 2026 | 2.63 | 2.79 | 2.620 | 2.77 | 952160.0 |
| Sep 11, 2026 | 2.74 | 2.75 | 2.615 | 2.64 | 646807.0 |
| Sep 10, 2026 | 2.66 | 2.735 | 2.64 | 2.73 | 782524.0 |
| Sep 09, 2026 | 2.68 | 2.68 | 2.595 | 2.67 | 580004.0 |
| Sep 08, 2026 | 2.66 | 2.67 | 2.60 | 2.65 | 908364.0 |
| Sep 04, 2026 | 2.62 | 2.68 | 2.615 | 2.67 | 863718.0 |
| Sep 03, 2026 | 2.59 | 2.665 | 2.57 | 2.62 | 942012.0 |
| Sep 02, 2026 | 2.59 | 2.64 | 2.585 | 2.59 | 454863.0 |
| Sep 01, 2026 | 2.61 | 2.67 | 2.565 | 2.59 | 598263.0 |
| Aug 31, 2026 | 2.55 | 2.61 | 2.525 | 2.57 | 748350.0 |
| Aug 28, 2026 | 2.61 | 2.62 | 2.53 | 2.54 | 490228.0 |
| Aug 27, 2026 | 2.49 | 2.65 | 2.48 | 2.61 | 1.294M |
| Aug 26, 2026 | 2.39 | 2.48 | 2.36 | 2.48 | 1.024M |
| Aug 25, 2026 | 2.43 | 2.43 | 2.38 | 2.40 | 497742.0 |
| Aug 24, 2026 | 2.36 | 2.43 | 2.34 | 2.41 | 409933.0 |
| Aug 21, 2026 | 2.39 | 2.435 | 2.35 | 2.38 | 648550.0 |
| Aug 20, 2026 | 2.32 | 2.39 | 2.310 | 2.38 | 384984.0 |
| Aug 19, 2026 | 2.37 | 2.38 | 2.31 | 2.35 | 477242.0 |
| Aug 18, 2026 | 2.30 | 2.345 | 2.28 | 2.34 | 280506.0 |
| Aug 17, 2026 | 2.24 | 2.365 | 2.22 | 2.29 | 1.076M |
| Aug 14, 2026 | 2.36 | 2.36 | 2.17 | 2.22 | 995919.0 |
| Aug 13, 2026 | 2.64 | 2.64 | 2.32 | 2.36 | 2.002M |
| Aug 12, 2026 | 2.49 | 2.705 | 2.40 | 2.62 | 2.012M |
| Aug 11, 2026 | 2.47 | 2.48 | 2.410 | 2.43 | 373853.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Altimmune, Inc. | 3.24 |
| Taysha Gene Therapies, Inc. | 5.10 |
| Humacyte, Inc. | 0.5692 |
| Agenus, Inc. | 7.16 |
| Amgen, Inc. | 375.61 |
Price Related Metrics
| PE Ratio | 11.62 |
| PS Ratio | 2.676 |
| PEG Ratio | 0.0562 |
| Price to Book Value | 2.979 |
| Price to Free Cash Flow | 28.13 |
| Earnings Yield | 8.60% |
| Market Cap | 212.71M |
| PEGY Ratio | 0.0562 |
| Operating PE Ratio | 9.262 |
| Normalized PE Ratio | 11.63 |